Susceptibility rate (%) |
||||
---|---|---|---|---|
Inducible Enterobacteriaceae* |
Non-inducibleEnterobacteriaceae# |
|||
<48 h | ≥48 h | <48 h | ≥48 h | |
Entrapenem | 96 | 94 | 97 | 97 |
Imipenem | 97 | 96 | 98 | 98 |
Cefepime | 94 | 87 | 93 | 81 |
Cefotaxime | 79 | 59 | 93 | 81 |
Cefoxitin | 27 | 24 | 93 | 81 |
Ceftazidime | 77 | 57 | 92 | 79 |
Ampicillin/Sulbactam | 34 | 21 | 62 | 43 |
Piperacillin/Tazobactam | 34 | 21 | 62 | 43 |
Amikacin | 99 | 93 | 97 | 95 |
Ciprofloxacin | 91 | 83 | 84 | 70 |
Levofloxacin | 93 | 88 | 86 | 72 |
Length of hospitalisation not reported for 6* & 33# isolates.